Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
76.3M
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
494K
-
Shares change
-
+25K
-
Total reported value, excl. options
-
$19.9M
-
Value change
-
+$1.17M
-
Number of buys
-
11
-
Number of sells
-
-8
-
Price
-
$40.28
Significant Holders of CG Oncology, Inc. - Common Stock (CGON) as of Q3 2025
27 filings reported holding CGON - CG Oncology, Inc. - Common Stock as of Q3 2025.
CG Oncology, Inc. - Common Stock (CGON) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 494K shares
of 76.3M outstanding shares and own 0.65% of the company stock.
Largest 10 shareholders include MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (248K shares), iA Global Asset Management Inc. (48.7K shares), Voya Investment Management LLC (48K shares), AMI ASSET MANAGEMENT CORP (44.1K shares), TEMA ETFS LLC (30.2K shares), Sicart Associates LLC (25K shares), SG Americas Securities, LLC (10.9K shares), TEACHER RETIREMENT SYSTEM OF TEXAS (10.3K shares), KLP KAPITALFORVALTNING AS (8.1K shares), and CWM, LLC (6.87K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.